Company Filing History:
Years Active: 2016-2025
Title: Innovations of Markus Pitkanen
Introduction
Markus Pitkanen is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of pharmaceutical product development, holding two patents that showcase his innovative approach to biological fluid processing.
Latest Patents
One of his latest patents is a system and method for a pharmaceutical product. This invention relates to a biological fluid processing system and method that includes a fluid processing device with at least one fluid path, a pump for providing pressure, and a valve controlled by an actuator. The system is designed to be modular, allowing for flexibility in its configuration. Another patent involves a display screen with a graphical user interface for a filtration system, enhancing user interaction and operational efficiency.
Career Highlights
Throughout his career, Markus has worked with prominent companies such as GE Healthcare Biosciences AB and Cytiva Sweden AB. His experience in these organizations has allowed him to refine his skills and contribute to advancements in healthcare technology.
Collaborations
Markus has collaborated with notable professionals in his field, including Klaus Gebauer and Hakan Lundstrom. These partnerships have fostered innovation and the development of cutting-edge solutions in the pharmaceutical industry.
Conclusion
Markus Pitkanen's work exemplifies the spirit of innovation in the pharmaceutical sector. His patents and career achievements reflect his commitment to advancing technology for better healthcare solutions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.